Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Dec 1;63(12):3211-3220.
doi: 10.1093/rheumatology/keae198.

The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis

Affiliations
Meta-Analysis

The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis

Stephanie Lembke et al. Rheumatology (Oxford). .

Abstract

Objectives: Previous attempts to pool prevalence studies in PsA have failed to take account of important methodological differences between studies that may have created biased estimates. The aim of this review is to estimate the prevalence of PsA within the adult general population worldwide, considering potential differences between population-based and health administrative studies separately.

Methods: Four electronic databases were systematically searched for articles reporting the prevalence of PsA. Data were pooled to generate worldwide prevalence estimates. Where sufficient data were available, results were summarized by continent.

Results: Thirty studies were identified, with half from Europe (n = 15). Thirteen population-based studies were identified comprising >92 000 adults, plus 17 studies (>180 million adults) based on health administrative data. The worldwide prevalence of PsA was 112 per 100 000 adults. The prevalence of PsA estimated using population-based studies was 113 per 100 000 with continent-specific estimates of 207 (Europe), 64 (North America) and 37 (Asia) per 100 000. Health administrative studies gave a global prevalence of 109 per 100 000 with continent-specific prevalence of 175 (Europe), 147 (North America), 78 (Asia) and 17 (South America).

Conclusion: This review compiles currently available estimates of PsA prevalence in the general population into global and continent-based estimates and considers important study design characteristics. There is wide variability between continents, and data in some geographical areas are sparse, but available evidence suggests that PsA is more common in Europe and North America compared with Asia and South America, and current best estimates suggest a global prevalence of 112 per 100 000 adults.

Keywords: epidemiology; meta-analysis; prevalence; psoriatic arthritis; systematic review.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram for study selection during literature review. In accordance with the PRISMA reporting guidelines [16]
Figure 2.
Figure 2.
Worldwide prevalence of PsA (population-based studies)
Figure 3.
Figure 3.
Worldwide prevalence of PsA (health administrative data studies)

References

    1. FitzGerald O, Ogdie A, Chandran V et al. Psoriatic arthritis. Nat Rev Dis Primers 2021;7:(59. - PubMed
    1. Scott IC, Whittle R, Bailey J et al. Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data. Lancet Reg Health—Eur 2022;23:100519. - PMC - PubMed
    1. Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res 2016;68:1320–31. - PubMed
    1. Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2018;48:28–34. - PubMed
    1. Alinaghi F, Calov M, Kristensen LE et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 2019;80:251–65.e19. - PubMed

Grants and funding